Effect of Pharmacist Involvement in COVID-19 Vaccination Campaign on Vaccine Coverage

Abstract To address the COVID-19 pandemic, promoting vaccination emerged as a preferred strategy to mitigate the harmful consequences of non-pharmaceutical interventions. In Europe, a measure adopted by several states was to authorize pharmacists to administer vaccines. The objective of this chapter is to assess whether this involvement could improve vaccination coverage. To do this, the synthetic control group method is used, due to a European framework conducive to its establishment. The results show an improvement in coverage with the first dose in Italy, but a degradation with the second dose. In Ireland, the opposite situation is observed. In France, due to the early adoption of the measure, no significant results were obtained. These elements imply for the legislator that the pharmacist can have different effects on vaccination coverage and that this must be considered taking into account epidemiological and vaccine issues, the spatial distribution of healthcare provision, and potentially its regulation.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11387516/v1
Primary Topic
Vaccine Coverage and Hesitancy
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Effect of Pharmacist Involvement in COVID-19 Vaccination Campaign on Vaccine Coverage

Aniss Malik LOUCHEZ
2 links
Research Square
Vaccine Coverage and Hesitancy
preprint

Effect of Pharmacist Involvement in COVID-19 Vaccination Campaign on Vaccine Coverage

Aniss Malik LOUCHEZ
preprint en

Abstract

Abstract To address the COVID-19 pandemic, promoting vaccination emerged as a preferred strategy to mitigate the harmful consequences of non-pharmaceutical interventions. In Europe, a measure adopted by several states was to authorize pharmacists to administer vaccines. The objective of this chapter is to assess whether this involvement could improve vaccination coverage. To do this, the synthetic control group method is used, due to a European framework conducive to its establishment. The results show an improvement in coverage with the first dose in Italy, but a degradation with the second dose. In Ireland, the opposite situation is observed. In France, due to the early adoption of the measure, no significant results were obtained. These elements imply for the legislator that the pharmacist can have different effects on vaccination coverage and that this must be considered taking into account epidemiological and vaccine issues, the spatial distribution of healthcare provision, and potentially its regulation.

Research Square
Université de Lille (FR)
Good health and well-being
Vaccine Coverage and Hesitancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon